15.03.2012 • NewsHovioneGuy VillaxGuy Villax Hovione

Colin Minchom Appointed VP Particle Design BU at Hovione

Hovione said it has appointed Dr. Colin Minchom as vice president of its Particle Design business unit. Dr. Minchom was most recently with Patheon where he held the position of vice president, Pharmaceutical Development Services for North America. Based in East Windsor, NJ, Dr. Minchom will report to Hovione CEO Guy Villax.

Dr. Minchom's 29-year career includes extensive experience in the process, science and global regulation of drug development with emphasis on dosage forms and drug delivery. Prior to this role at Patheon, Dr. Minchom was head of Pharmaceutical Sciences at Cerebrus, a UK privately held pharmaceutical company and has also held positions of increasing scientific and management responsibility at Eli Lilly and E.R. Squibb in formulation and product development, project management and product management.

 

 

Company

Hovione

Sete Casas
2674-506 Loures
Portugal

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read